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Abstract
We validated a Fitbit sleep tracking device against typical research-use actigraphy across four nights on 38 young 
adults. Fitbit devices overestimated sleep and were less sensitive to differences compared to the Actiwatch, but 
nevertheless captured 88 (poor sleepers) to 98 percent (good sleepers) of Actiwatch estimated sleep time changes. 
Bland–Altman analysis shows that the average difference between device measurements can be sizable. We therefore do 
not recommend the Fitbit device when accurate point estimates are important. However, when qualitative impacts are 
of interest (e.g. the effect of an intervention), then the Fitbit device should at least correctly identify the effect’s sign.
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Introduction
The usefulness and validity of research-grade actigraphy 
devices are well known (Sadeh, 2011). The rise in interest 
regarding consumer sleep tracking devices for research 
implies the need for testing such devices against accepted 
sleep monitoring technologies. This article reports results 
from a validation study of the Fitbit sleep tracking device 
against standard actigraphy. Fitbit is a leading maker of 
devices that claim to track sleep, although recent validation 
attempts have produced mixed results (Evenson et al., 2015; 
Meltzer et al., 2014; Montgomery-Downs et al., 2012). Other 
consumer sleep trackers have also been the subject of valida-
tion tests. Validation studies of the Jawbone UP device, for 
example, have produced similar mixed results (de Zambotti 
et al., 2015; Evenson et al., 2015; Toon et al., 2015). A sum-
mary of the claims and validity of numerous consumer 
sleep monitors is found in Russo et al. (2015), with a focus 
on the question of their possible usefulness even absent 
clinical-level data validity. Our study intends to contribute 
to this debate. As we will show, our data are somewhat in 
line with previous conclusions. We provide evidence sug-
gesting serious reservations about using the Fitbit device if 
accurate measurements are desired, but it may prove useful 
for qualitative purposes in certain settings.
Methods
This study adhered to the guidelines outlined in the 
Declaration of Helsinki as revised in 2008. We recruited 38 
adult participants (23 females, 15 males; 26.05 ± 7.99 years) 
who each simultaneously wore a commonly utilized 
research-grade actigraph (Actiwatch Spectrum Plus: Philips 
Respironics) and a popular commercial sleep tracker (Fitbit 
Charge HR) for 4 weekdays/nights. Both the Actiwatch and 
Fitbit were set to sample data at 30-second epochs, and the 
Fitbit was set to “normal” mode. We used the Pittsburgh 
Sleep Quality Index (PSQI; Buysse et al., 1989) to identify 
both good (PSQI ⩽ 5; n = 20) and poor sleepers (PSQI > 5). 
Participants kept sleep diaries, and we report both raw and 
diary-adjusted Fitbit data on total sleep time (TST) and 
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efficiency. The procedures used for diary-aided scoring of 
the Fitbit data were similar to validated actigraphy proce-
dures (Goldman et al., 2007). Because participants simulta-
neously wore both devices, this assured that the diary-aided 
scoring of both Fitbit and Actiwatch data utilized the exact 
same sleep diary record. Participants were compensated 
US$50 for participation, and procedures were approved by 
the Institutional Review Board in the Office of Research 
Protection at Appalachian State University (IRB approval 
#15-0325).
On the first day, participants visited our lab and pro-
vided written informed consent, completed the PSQI, 
received device instructions, and were assigned both an 
Actiwatch and a Fitbit device. Before departing, partici-
pants were instructed to return to the lab each day for 
approximately 20 minutes. During this time, they com-
pleted sleep diaries online and lab technicians synced Fitbit 
devices with lab computers and downloaded participants’ 
Fitbit and Actiwatch data from the previous day.
Statistical methods used
We compare each participant’s Fitbit nightly sleep meas-
ure to the analogous actigraphy-produced measure: time-
in-bed (TIB), TST, sleep efficiency (as automatically 
device-scored), and TST/TIB (which we call quasi- 
efficiency). As noted above, Actiwatch data are scored 
using validated procedures, and we examine Fitbit meas-
ures of TST using both raw and diary-adjusted data. To our 
knowledge, existing validation studies of consumer moni-
toring devices do not always adjust device data with input 
from sleep diaries, even though this is common in many 
research studies. Some devices require user activation of 
“sleep mode,” which may serve as a diary-type measure. 
The Fitbit Charge HR does not require such user activa-
tion. Also, some validation studies involve concurrent 
polysomnographic (PSG) data acquisition, but it is not 
always clear whether consumer device data are adjusted as 
part of the scoring procedure.
For each outcome measure, M, we estimate the follow-
ing linear model:
Fitbit Actigraphy( ) ( )M M= + × +α β ε  (1)
where ε is a random effects error term accounting for the 
multiple observations (n = 4) per participant (i.e. error terms 
are clustered by participant). The null hypotheses that both 
α = 0 and β = 1 imply Fitbit outcomes are statistically no dif-
ferent than Actiwatch outcomes on average. Rejection of 
α = 0 reflects a general over/underestimation by Fitbit of the 
actigraphy-based measure. Rejection of β = 1 indicates 
hypo- or hyper-sensitivity of the Fitbit to changes in the 
outcome measure, compared to actigraphy. All estimations 
of model (equation (1)) were performed using the panel 
data random effects option in Stata 13 software.
We also performed Bland–Altman analysis on the differ-
ences in device measurements (Bland and Altman, 1986). 
Enhanced Bland–Altman plots were constructed using SAS 
software, and these plots include the linear prediction and 
95 percent confidence interval on the difference between 
the outcome measures of the two devices (sleep time or 
sleep efficiency).
Finally, our unique longitudinal approach (most studies 
validate a device based on one night with PSG measures, 
for example) allows us to examine whether any systematic 
measurement differences between devices are a function of 
multiple measurements on the same participant.
All reported results are based on diary-adjusted (i.e. 
“scored”) Fitbit and Actiwatch measures, as is typically 
done with actigraphy data. Diary-adjusted scoring of the 
Fitbit data significantly reduces the variance in sleep out-
come measures from the Fitbit (see section “Results”). In 
fact, the correlation between the Actiwatch raw versus 
scored data is .9582, compared to .6327 between Fitbit raw 
versus scored data. Diary adjustments are used not to cali-
brate all the device data to match the diary, but rather the 
diary is used as a complement to the device data when sleep 
start/stop times are ambiguous in the device data record.
Results
Figure 1 and Table 1 summarize the key correlational 
results, while Figure 2 highlights the importance of the 
diary-aided scoring of the Fitbit data (i.e. manual adjust-
ments of raw Fitbit data similar to typical scoring proce-
dures used with actigraphy in sleep research studies). In 
Figure 1, the scatterplot Fitbit data measures (TST and effi-
ciency) are compared to the analogous Actiwatch measure, 
with the linear regression estimate of equation (1) superim-
posed. Table 1 shows the full estimation results of TST, sleep 
efficiency (shown in Figure 1), TIB, and quasi-efficiency 
(not shown in Figure 1) as well as estimates for the separate 
subsamples of good and poor sleepers. In most instances, 
Table 1 indicates that the Fitbit generally overestimates TIB, 
TST, and efficiency relative to the Actiwatch measure (i.e. 
rejection of α = 0 in favor of α > 0). The results most closely 
approximate α = 0 and β = 1 for the subsample of good 
sleepers, for whom we estimate that the Fitbit measure of 
TST is statistically indistinguishable from the Actiwatch 
TST measure. This correlational analysis does not, how-
ever, draw our attention to the differences between device 
measurements, which may be sizable and still produce a 
high correlation measure between devices.
Standard and enhanced Bland–Altman plots showing 
measurement differences between devices were constructed 
for TST, sleep efficiency, and quasi-efficiency measures. In 
Figures 3 to 5, we show results from analysis on the pooled 
sample as well as the subsamples of good and poor sleeper 
data for each of these measures. The enhanced plots (right-
hand side panel in each figure) include a linear prediction 
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Figure 1. Fitbit versus actigraphy (ordinary least squares line fit shown).
Table 1. FitBit outcome measures regressed against actigraphy measures.
TIB Dependent variable = Fitbit TIB
 (1) (2) (3)
Variable All subjects (n = 152) Good sleepers (PSQI ⩽ 5; n = 72) Poor sleepers (PSQI > 5; n = 80)
 Constant α 104.981 (22.035)*** 84.577 (27.908)*** 122.113 (31.93)***
 Actigraphy TIB β .854 (.048)*** .912 (.053)*** .803 (.072)***
 R2 .72 .74 .70
 Test of β = 1 X2(1) = 9.32*** X2(1) = 2.77* X2(1) = 7.48***
TST Dependent variable = Fitbit TST
Variable All subjects (n = 152) Good sleepers (PSQI ⩽ 5; n = 72) Poor sleepers (PSQI > 5; n = 80)
 Constant α 54.203 (18.649)*** 35.121 (22.013) 65.529 (25.247)***
 Actigraphy TST β .917 (.050)*** .974 (.056)*** .879 (.071)***
 R2 .83 .84 .83
 Test of β = 1 X2(1) = 2.69* X2(1) = .21 X2(1) = 2.92*
TST/TIB Dependent variable = Fitbit quasi-efficiency (TST/TIB)
Variable All subjects (n = 152) Good sleepers (PSQI ⩽ 5; n = 72) Poor sleepers (PSQI > 5; n = 80)
 Constant α 19.342 (13.175) 10.212 (10.845) 24.656 (22.440)
 Actigraphy TST/TIB β .742 (.140)*** .840 (.117)*** .685 (.238)***
 R2 .26 .38 .19
 Test of β = 1 X2(1) = 3.39* X2(1) = 1.87 X2(1) = 1.75
Efficiency Dependent variable = Fitbit efficiency (device defined)
Variable All subjects (n = 152) Good sleepers (PSQI ⩽ 5; n = 72) Poor sleepers (PSQI > 5; n = 80)
 Constant α 76.096 (5.432)*** 85.413 (1.767)*** 69.368 (10.140)***
 Actigraphy efficiency β .207 (.061)*** .105 (.021)*** .279 (.115)**
 R2 .19 .19 .21
 Test of β = 1 X2(1) = 168.72*** X2(1) = 1861.60*** X2(1) = 39.61***
TIB: time in bed; TST: total sleep time.
Random effects regression models with errors clustered by participant (four observations per participant). Robust standard errors shown in paren-
thesis. Statistical equivalence between actigraphy and Fitbit outcome variable implies α = 0, β = 1.
*, **, ***Significance at the .10, .05, and .01 levels, respectively, for the two-tailed test.
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of the measurement difference and confidence intervals on 
that difference.
From Figures 3 to 5, we see a key concern regarding 
device point-estimate reliability of the Fitbit. In many 
instances, the difference in sleep parameter measurement is 
not only outside the random variation one might expect, but 
also the magnitude of the differences is substantial. Also, the 
Bland–Altman plots reveal that longer recorded values of 
Fitbit TST or sleep efficiency are associated with an even 
larger difference between the sleep parameters that the Fitbit 
and Actiwatch are measuring. Given the Actigraph Spectrum 
is a well-validated and commonly used research device for 
obtaining such sleep measures (i.e. it is our benchmark 
device between the two), this finding indicates that the Fitbit 
is not sufficiently accurate in the precision of its measure-
ments compared to well-accepted device standards.
Finally, we also conducted longitudinal analysis on 
whether the day of testing (day 1, 2, 3, or 4) revealed any 
systematic tendencies regarding the difference between 
Fitbit and Actiwatch device measurements. The longitudi-
nal data on each participant are shown in Figures 6 and 7, 
which in each case are separated by good and poor sleepers. 
One can see that the data show that the Fitbit tends to over-
estimate sleep efficiency and marginally overestimate TST 
across all days, but regression results in Tables 2 and 3 con-
firm no systematic trend across days. Thus, the Fitbit may 
yet provide useful information regarding the qualitative 
change in a participant’s sleep trends, even though the spe-
cific values are likely biased.
Discussion
Given the prevalent use of actigraphy for monitoring par-
ticipant sleep levels outside of a sleep laboratory 
environment, we aimed to assess the practical usefulness 
of the Fitbit device as an alternative to actigraphy in cer-
tain contexts. The National Sleep Foundation places sig-
nificant emphasis on sleep level targets and guidelines, 
and they routinely identify sleep deficits by comparing 
nightly sleep guidelines to self-report measures. One use 
of low-cost sleep monitoring devices may be to help 
assess within-participant sleep trends in settings where 
clinical accuracy is not necessary. In other words, con-
sumer sleep tracking devices may still be qualitatively 
useful for personal goal tracking or even some applied 
research purposes (e.g. Did intervention X significantly 
increase John Doe’s nightly sleep?).
Our statistical analysis finds that diary-adjusted Fitbit 
data show fairly reasonable correlation on the key TST 
variable for good sleepers and somewhat lower but still 
high correlation on TST for poor sleepers. The regression 
fit between Actiwatch and Fitbit sleep efficiency (and it is 
unclear how that is defined with Fitbit) is inferior, which 
suggests that perhaps the use of the quasi-efficiency meas-
ure, TST/TIB, may be more reasonable. Nevertheless, the 
correlation between Fitbit and Actiwatch quasi-efficiency 
is substantially lower than the correlation between their 
TST measures.
Additional analysis with Bland–Altman plots show that 
the magnitude of the differences between device measure-
ments can be substantial. In some instances, the difference 
in nightly sleep measured by the Fitbit is more than a full 
hour different from the analogous Actiwatch measure. 
Also, confidence intervals on the predicted difference 
between device measurements as a function of the Fitbit 
measure typically do not include the “zero difference” line, 
and the predicted difference in device measurements is not 
constant across the range of values in our data set. Finally, 
Figure 2. Fitbit scored versus raw nightly TST data compared to actigraphy (ordinary least squares line fit shown).
Left panel of Figure 2 reproduces the left panel of Figure 1 with axis rescaled for comparability with raw Fitbit data.
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we exploit the unique longitudinal nature of our data set by 
examining whether the difference between Fitbit and 
Actiwatch measures of TST and sleep efficiency differs 
systematically over the course of the four evenings of data 
Figure 3. Bland–Altman plots—total sleep time (TST). 95 percent confidence interval shown.
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collection—such analysis is not possible with typical vali-
dation studies examining only a single night of device test-
ing. We do not find evidence of differences in device 
measurement differences across consecutive evenings of 
testing. Overall, while the Fitbit may be useful for promot-
ing a heightened awareness and concern over one’s sleep, 
Figure 4. Bland–Altman plots—efficiency (device-scored). 95 percent confidence interval shown.
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Figure 5. Bland–Altman plots—quasi-efficiency (TST/TIB). 95 percent confidence interval shown.
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we do not recommend it as an alternative to traditional 
actigraphy when accurate point estimates of TST or sleep 
efficiency are desired. However, the significant positive 
average relationship between device measurements 
Figure 6. Fitbit–Actiwatch longitudinal TST device differences.
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suggests a limited but useful role for the Fitbit for those 
instances where the average sign of the effect is all the 
researcher needs (e.g. assessing the directional impact of an 
intervention, assuming sufficient sample size). The qualita-
tive value of the Fitbit data appears to be present for both 
good and poor sleepers.
Figure 7. Fitbit–Actiwatch longitudinal device-measured sleep efficiency differences.
10 Health Psychology Open 
Table 2. Longitudinal analysis of the difference between Fitbit TST and Actiwatch TST (dependent variable is Fitbit TST–Actiwatch 
TST).
Variable All subjects (n = 152) Poor sleepers (n = 80) Good sleepers (n = 72)
Constant 13.737 (7.526)* 9.900 (11.926) 18.000 (9.317)*
Day 2 12.500 (9.675) 7.675 (15.596) 17.861 (11.550)
Day 3 10.658 (7.577) 17.400 (12.083) 3.167 (9.017)
Day 4 11.868 (7.526) 16.125 (11.926) 7.139 (9.445)
Model test (X2) 2.37 4.46 2.46
Random effects regression models with errors clustered by participant (four observations per participant). Robust standard errors shown in paren-
thesis. Impact of each identified day in the study timeline is in comparison with day 1 (the omitted reference group in the set of indicator variables).
*, **, ***Significance at the .10, .05, and .01 levels, respectively, for the two-tailed test.
Table 3. Longitudinal analysis of the difference between Fitbit sleep efficiency and Actiwatch sleep efficiency (dependent variable is 
Fitbit efficiency–Actiwatch efficiency).
Variable All subjects (n = 152) Poor sleepers (n = 80) Good sleepers (n = 72)
Constant 6.684 (.883)*** 7.100 (1.366)*** 6.222 (1.146)***
Day 2 .105 (1.014) −1.850 (1.509) 2.278 (1.202)*
Day 3 .632 (1.341) −.400 (1.919) 1.778 (1.926)
Day 4 1.632 (1.804) 1.900 (2.600) 1.333 (2.623)
Model test (X2) .94 4.48 3.63
Random effects regression models with errors clustered by participant (four observations per participant). Robust standard errors shown in paren-
thesis. Impact of each identified day in the study timeline is in comparison with day 1 (the omitted reference group in the set of indicator variables).
*, **, ***Significance at the .10, .05, and .01 levels, respectively, for the two-tailed test.
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